Ads
related to: drug relapse
Search results
Drug Court alumni and enrollees holding 'Walk for Recovery' on Monday in Centralia, public invited...
The Chronicle, Centralia, Wash. via Yahoo News· 6 days agoMay 10—On Monday, May 13, beginning at 5:30 p.m., Lewis County Drug Court alumni and current enrollees will set out for the 2024 Walk for Recovery from Gather Church's cafe ...
Community ordinances are clashing with Michigan’s drug harm reduction strategy
Gannett via AOL· 4 days agoAmong those supplies: Kits to determine whether drugs contain fentanyl, the synthetic opioid that is...
Kirill Vesselov's Resources Unveil New Recovery Features in Boca Raton
Digital Journal· 9 hours agoIntegration of Holistic... Interviewing, to foster behavioral change and support recovery efforts....
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoA third cohort includes treating refractory relapsed AML patients who are venetoclax resistant or intolerant with the two-drug combination of prexigebersen ...
Hadley man arrested on charges of stolen vehicle, methamphetamine
The Daily Globe, Worthington, Minn. via Yahoo News· 3 days agoMay 13—SLAYTON — A Hadley man faces charges in Murray County Fifth District Court of felony-level theft of a motor vehicle, receiving stolen property and methamphetamine-related crimes involving ...
US overdose deaths decline for first time in 5 years as Michigan sees dip, too
Detroit Free Press· 2 days agoThe number of people who died as a result of drug overdoses declined by 3% across the nation last...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WJTV Jackson· 2 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 22 hours agoThe FDA extended the review time for the above BLA... (lisocabtagene maraleucel; liso-cel). The...
FDA Approves Tarlatamab for Extensive-Stage SCLC
Medscape· 1 day agoContinued approval of the first-in-class bispecific T-cell engager (BiTE) may depend on proof of clinical benefit.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoMoleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON, May 16, 2024 HOUSTON, May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or
Ads
related to: drug relapse
